Not exact matches
And a new analysis of the STEP trial, published last November in Proceedings of the National Academy of Sciences USA, provides a warning that the very vectors (adenoviruses, which are also employed in other vaccine development work) used to distribute the inactive HIV strains can actually make the
immune system more vulnerable to infection by recruiting susceptible T
cells to mucous membranes, where they are more likely to be
infected during sexual activity.
«Scientists find potential mechanism for deadly, sepsis - induced secondary infection: Sepsis disrupts
immune cell recruitment to
infected skin in mice.»
In such patients, a phenomenon called «antibody - dependent enhancement» (ADE) takes place, during which antibodies that were generated during the first infection bind but do not destroy the slightly different newly
infecting virus, but instead facilitate its infection of
immune cells.
And then we
infect bone marrow
cells with the vector — those
cells ultimately give rise to the
immune system.
The team found that the number of gamma delta T -
cells was higher in the CMV -
infected babies, and that a greater proportion of these
immune cells were activated.
Thomas speculated that as many as 10 percent of T
cell receptors are outliers that help the
immune system recognize and rapidly respond to mutations that might otherwise help virus -
infected cells and other threats delay detection.
The human
immune system is adept at recognizing antigens it has met before: Antibodies snap onto the projecting viral proteins and prevent the organism from
infecting other
cells.
The
immune system depends on molecules called T
cell receptors on the surface of T
cells to recognize and respond to foreign antigens from virus -
infected cells, tumors and other threats.
«We hypothesized that individual mutations in viral genes could be expected to have a range of effects on the virus's ability to replicate, to
infect new
cells and escape the
immune system,» Carlson says.
The Boston patients, in contrast, are free of the virus thanks to a combination of a bone marrow transplant plus continuing antiretroviral drugs to stop newly donated
immune cells from being
infected.
An unknown component of breast milk appears to kill HIV particles and virus -
infected cells, as well as blocking HIV transmission in mice with a human
immune system.
In the body, MHCI proteins are watchdogs, tagging
infected cells for
immune attack.
The researchers speculate that the beetle's revived
immune system discovers and attacks DCPV -
infected cells.
The researchers found that HIV spiked into semen was more successful than the virus alone at
infecting T
cells and macrophages (
immune system
cells that are believed to be the infection's initial targets in the body).
In the presence of Acinetobacter and Akkermansia, they became a particular type of T helper
cell, which trigger inflammation and help the
immune system kill off invaders or
infected cells, the researchers report today in the Proceedings of the National Academy of Sciences (PNAS).
In this antibody - dependent enhancement, the antibodies inadvertently increase the virus's ability to
infect immune cells, leading to more serious symptoms.
Gobardhan Das and colleagues at the International Centre for Genetic Engineering and Biotechnology in New Delhi, India, found that in
infected organs of mice with TB, but not in healthy mice,
immune cells called T -
cells are suppressed.
By studying
infected cells grown in a laboratory, the team found that a large number of CMV's genes help it hide from the
immune system by allowing it to destroy many of the proteins produced by the body during virus infection and preventing them from activating
immune cells to destroy the virus.
Antibodies derived from a type of
immune cell found in unusually high numbers in HIV -
infected individuals with chronically uncontrolled virus levels are less effective at neutralizing HIV than antibodies derived from a different type of
immune cell more common in people without HIV, scientists report.
After almost a decade of effort, crystallographers have achieved a major goal in AIDS research: They have determined the detailed structure of the protein HIV uses to
infect immune cells called T lymphocytes.
Then it
infects various
cells of the
immune system, which it tricks into making more copies of itself.
While the individual effects of the drugs on virus - specific CTL differ somewhat depending on specific assays, schedules, and doses, treatment with any of the three HDAC inhibitors impaired the ability of CTL to kill HIV -
infected immune cells.
Dr. Cripe and his colleagues at The Ohio State University, the University of Pittsburgh School of Medicine and Cincinnati Children's Hospital Medical Center tested how well the oncolytic viral therapy — a cancer - killing form of the herpes simplex virus, called oHSV —
infected and killed tumor
cells in mice with and without a healthy
immune system.
Newburg and his collaborators are also studying a human - milk fat that seems to inhibit HIB from
infecting human
cells, and yet another milk component that prevents hiv from disabling the host's
immune cells.
Epigenetic therapies are thought to work in two ways to fix these errors in cancer
cells — by correcting the «position» of the gene switches and by making the
cell appear as though it's
infected by a virus, triggering the
immune system.
In each case, the mRNA encodes viral proteins that
infected cells would normally present to activate the
immune system and beat back an infection.
This made it possible for their
immune systems to produce sufficient amounts of CD8 T
cells that were primed to attack and kill HIV -
infected cells.
«When mosquitoes are
infected with these viruses, there's a signal that lets the mosquito's
cells know that they are
infected, resulting in targeting of the virus by the mosquito's
immune response.
This is an illustration of how the engineered protein facilitates destruction of latently HIV -
infected immune cells.
HIV can either be spread through free - floating virus that directly
infect the host
immune cells or an
infected cell can pass the virus to an uninfected
cell.
«Something similar occurs in our bodies when we're
infected with these viruses; there are signals our
cells detect that let our
immune system know all is not well,» he said.
The new study revives suspicions that adenoviruses cause an
immune «own goal», priming people's
immune systems to produce CD4
cells — the very
cells that HIV prefers to
infect — and, worse still, to direct those
cells to the parts of the body that are most vulnerable to the virus during sex.
When pathogens
infect the
cells of the body, the infection sets off a chain reaction involving the
immune system that changes the activity, or expression, of hundreds of genes.
Two new studies reveal that administering a potent, broadly neutralizing antibody that binds to HIV evokes a strong
immune response in humans, and can even accelerate the clearance of
infected cells.
They nicknamed it «Delta 20,» an
immune system protein that suppresses the most damaging HIV strains, X4, by preventing the virus from
infecting cells.
Although
cell - to -
cell infection does result in release of abundant solo viral particles, direct transmission from HIV -
infected immune cells to other
cells — which can then replicate in clusters of these
cells — is a much more efficient route to quickly spread the virus, researchers say.
Flu virus needs NS1 to prevent interferon, the
immune system's front line against viruses, from alerting the host
cell that it has been
infected.
Current laureates in residence include Peter Doherty, who shared the 1996 prize for discovering how the body's
immune system recognizes virus -
infected cells, and Barry Marshall and Robin Warren, who received the award last year for their discovery that the bacterium Heliobacter pylori causes stomach ulcers and gastritis.
He is using the virus to cure a rare form of blood cancer called EBV lymphoma, caused when B lymphocyte
immune cells get
infected with the Epstein - Barr virus (EBV).
Professor Dan Davis and his team at the Manchester Collaborative Centre for Inflammation Research, working in collaboration with global healthcare company GSK, investigated how different types of
immune cells communicate with each other — and how they kill cancerous or
infected cells.
HIV
infects the body by corrupting T
cells that are mobilized by the
immune system when the virus enters a person's body.
Among the protagonists are B
cells, which produce antibody molecules able to neutralize pathogens or mark them for destruction, and T
cells, which prompt
infected cells to kill themselves or secrete chemicals that direct the activities of other
immune players.
Particularly prominent in the RNA - Seq analysis was the up - regulation of a number of granzymes, a group of proteinases secreted by
immune cells that were originally thought to be involved in killing (via apoptosis) virus
infected cells or other target
cells.
«When a person is
infected with HIV, the virus
infects immune cells and knocks out the body's interferon production; the first line of defence in our bodies.
They found that indeed, they do, and that stimulating these
cells led them to kill
cells infected with HIV - 1 derived from latently
infected cells, both in culture and in mice engineered to have a human
immune system.
After
infecting the respiratory tract, the virus hijacks the
immune system's white blood
cells, using them to spread in the body — including to the skin to cause chickenpox.
But
immune warriors called cytotoxic T
cells often attack the virus -
infected cells.
Questions the group hopes to answer over the next five years include if LRAs will promote the expression of viral protein on the surface of
infected cells, and if pairing LRAs with
immune interventions will lead to the clearance of persistent, latent infection.
And a new analysis of the stopped STEP trial, published online Monday in Proceedings in the National Academy of Sciences, provides a warning that the very vectors (adenoviruses, which are also employed in other vaccine development) used to distribute the inactive HIV strains can actually prime the
immune system to be
infected by recruiting susceptible T
cells to mucous membranes, where they are more likely to be
infected during sexual activity.
Next, T
cells — the
immune system's foot soldiers — are harvested from the patient's blood and
infected with the virus, which rewrites their genetic code to recognize and destroy cancer
cells.